Department of Implantology, School and Hospital of Stomatology, Cheeloo College of Medicine, Shandong University & Shandong Key Laboratory of Oral Tissue Regeneration & Shandong Engineering Laboratory for Dental Materials and Oral Tissue Regeneration, Shandong University, Jinan.
Department of Implantology, Binzhou Central Hospital, Binzhou.
Medicine (Baltimore). 2021 Apr 23;100(16):e25507. doi: 10.1097/MD.0000000000025507.
Long noncoding RNA (lncRNA) is reported to be upregulated in many tumors. Although the expression of lncRNA in oral squamous cell carcinoma has been assessed, the association between lncRNA expression and prognosis or clinicopathological feature still remains controversial. Therefore, we conducted a meta-analysis to verify whether lncRNA expression was related to prognosis or clinicopathological features in patients with oral squamous cell carcinoma.
We searched Embase, PubMed, Web of Science, Cochrane library, Chinese National Knowledge Infrastructure, and Wanfang databases from inception to February 2021. The language included Chinese and English. The published literature on lncRNA expression and prognosis or clinicopathological characteristics of patients with oral squamous cell carcinoma was statistically analyzed. The combination of hazard ratios (HRs), odds ratios (OR), and 95% confidence intervals (95% CIs) were applied to evaluate the effects of lncRNA on the prognosis and clinicopathological features of oral squamous cell carcinoma.
This study could provide a comprehensive review of the available evidence of lncRNA on the prognosis and clinicopathological features of oral squamous cell carcinoma.
The conclusion of our study will provide the updated evidence to judge the lncRNA on the prognosis and clinicopathological features of oral squamous cell carcinoma.
长链非编码 RNA(lncRNA)在许多肿瘤中表达上调。尽管已经评估了 lncRNA 在口腔鳞状细胞癌中的表达,但 lncRNA 表达与预后或临床病理特征之间的关联仍存在争议。因此,我们进行了一项荟萃分析,以验证 lncRNA 表达是否与口腔鳞状细胞癌患者的预后或临床病理特征相关。
我们从建库到 2021 年 2 月在 Embase、PubMed、Web of Science、Cochrane 图书馆、中国国家知识基础设施和万方数据库中搜索了有关 lncRNA 表达与口腔鳞状细胞癌患者预后或临床病理特征的文献,并进行了统计学分析。采用风险比(HRs)、优势比(OR)和 95%置信区间(95% CIs)的组合来评估 lncRNA 对口腔鳞状细胞癌预后和临床病理特征的影响。
本研究可以提供 lncRNA 对口腔鳞状细胞癌预后和临床病理特征的现有证据的综合评价。
我们研究的结论将为判断 lncRNA 对口腔鳞状细胞癌预后和临床病理特征的影响提供最新的证据。